Finance

Lists
Why is SGHT down 6.41%?
Dive Deeper
SGHT:NASDAQ
Sight Sciences Inc
$8.39
-6.41%
(-0.57) 1D
$8.39
0.00% (0.00)
After hours
Closed: Oct 13, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGHT...
Open
$8.96
High
$8.99
Low
$8.30
Mkt. cap
461.93M
Avg. vol.
281.02K
Volume
413.50K
52-wk high
$9.71
52-wk low
$3.22
EPS
-$0.56
Beta
2.45
Shares outstanding
55.09M
No. of employees
186
Open
$8.96
High
$8.99
Low
$8.30
Mkt. cap
461.93M
Avg. vol.
281.02K
Volume
413.50K
52-wk high
$9.71
52-wk low
$3.22
EPS
-$0.56
Beta
2.45
Shares outstanding
55.09M
No. of employees
186
News stories
From web sources and news partners
About Sight Sciences Inc
CEO-
Employees186
Founded2010
Headquarters-
SectorMedical device
Websitesightsciences.com
Analyst ratings
Based on 7 analysts giving stock ratings to SGHT in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for SGHT in the last 3 months.
Highest
Current $8.39
$12.00 (+43.03%)
Average
$9.40 (+12.04%)
Lowest
$8.00 (-4.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Hold
Reiterated
$10.00
+19.2%
10/05/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$12.00
+43%
08/19/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/06/2026
Thomas Stephan
Stifel Nicolaus
Buy
Maintained
$8.00
-4.6%
08/06/2026
Patrick Wood
UBS
Buy
Maintained
$8.00
-4.6%
08/06/2026
David Saxon
Needham
Hold
Maintained
-
-
08/06/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
$9.00
+7.3%
08/06/2026
Danielle Antalffy
UBS
Buy
Maintained
$8.00
-4.6%
08/06/2026
Ryan Meyers
Lake Street
Buy
Reiterated
$12.00
+43%
08/05/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
-$0.08 / -$0.14
+42.85%beat
Revenue / Est. (USD)
23.39M / 21.71M
+7.73%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.91M
20.38M
19.70M
23.39M
Cost of goods sold
2.71M
2.60M
2.72M
2.01M
Cost of revenue
2.71M
2.60M
2.72M
2.01M
Research and development expenses
2.35M
2.44M
2.55M
2.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.95M
19.02M
21.44M
22.75M
Operating expense
22.30M
21.46M
23.99M
25.26M
Total operating expenses
25.01M
24.05M
26.71M
27.28M
Operating income
-5.10M
-3.67M
-7.01M
-3.89M
Other non operating income
-2.00K
-30.00K
-29.00K
82.00K
EBT including unusual items
-8.25M
-4.15M
-12.97M
-4.42M
EBT excluding unusual items
-5.45M
-4.15M
-7.57M
-4.42M
Income tax expense
-79.00K
8.00K
11.00K
28.00K
Effective tax rate
0.96%
-0.19%
-0.08%
-0.63%
Other operating expenses
-
-
-
-
Net income
-8.17M
-4.16M
-12.98M
-4.45M
Net profit margin
-41.04%
-20.42%
-65.89%
-19.01%
Earnings per share
-0.16
-0.08
-0.24
-0.08
Interest and investment income
965.00K
834.00K
741.00K
678.00K
Interest expense
-1.31M
-1.29M
-1.27M
-1.29M
Net interest expenses
-341.00K
-455.00K
-527.00K
-612.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.00M
-3.56M
-6.91M
-3.79M
Gain or loss from assets sale
4.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps